Pet Healthcare in Japan industry profile provides top-line qualitative and quantitative summary information including: market size (value and volume 2019-24, and forecast to 2029). The profile also contains descriptions of the leading players including key financial metrics and analysis of competitive pressures within the market.
Key Highlights
- The pet healthcare market includes retail sales of worming treatments, grooming products, pet supplements, external parasite treatments, and others. The scope of others includes dog dental products, fish & rodent health care products, other cat healthcare products, other cross-segment products, and other dog healthcare products. The market is valued according to retail selling price (RSP) and includes any applicable taxes.
- The Japanese pet healthcare market recorded revenues of $1.06 billion in 2024, representing a negative compound annual growth rate (CAGR) of 3.8% between 2019-24.
- Market consumption volume increased with a CAGR of 1.8% between 2019-24, reaching a total of 162.5 million units in 2024.
- The Japanese pet healthcare market experienced a negative value CAGR during the review period (2019-24) due to demographic shifts within the country. A shrinking and aging human population, coupled with declining birth rates, has led to fewer households a
Scope
- Save time carrying out entry-level research by identifying the size, growth, major segments, and leading players in the pet healthcare market in Japan
- Use the Five Forces analysis to determine the competitive intensity and therefore attractiveness of the pet healthcare market in Japan
- Leading company profiles reveal details of key pet healthcare market players’ global operations and financial performance
- Add weight to presentations and pitches by understanding the future growth prospects of the Japan pet healthcare market with five year forecasts by both value and volume
Reasons to Buy
- What was the size of the Japan pet healthcare market by value in 2024?
- What will be the size of the Japan pet healthcare market in 2029?
- What factors are affecting the strength of competition in the Japan pet healthcare market?
- How has the market performed over the last five years?
- What are the main segments that make up Japan's pet healthcare market?
Table of Contents
1 Executive Summary
2 Market Overview
3 Market Data
4 Market Segmentation
5 Market Outlook
6 Five Forces Analysis
7 Competitive Landscape
8 Company Profiles
9 Macroeconomic Indicators
10 Appendix
List of Tables
List of Figures
Companies Mentioned (Partial List)
A selection of companies mentioned in this report includes, but is not limited to:
- Virbac SA
- Elanco Animal Health Inc
- Fibro Pharmaceutical Co Ltd
- Fujita Pharmaceutical Co.,Ltd.
